A systems methodology to assess the risk of tumor relapse in melanoma by the profiling of plasma extracellular vesicles (MelEVIR)
Third Party Funds Group - Sub project
Acronym: MelEVIR
Start date : 01.04.2016
End date : 31.03.2019
Extension date: 31.05.2020
Germany (DE)